These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

165 related items for PubMed ID: 25113039

  • 1. The ratio of high-density lipoprotein cholesterol to apolipoprotein A-I predicts myocardial injury following elective percutaneous coronary intervention.
    Li XL, Li JJ, Guo YL, Zhu CG, Qing P, Wu NQ, Xu B, Gao RL.
    Clin Cardiol; 2014 Sep; 37(9):558-65. PubMed ID: 25113039
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Non-HDL cholesterol is a better target for predicting periprocedural myocardial injury following percutaneous coronary intervention in type 2 diabetes.
    Zeng RX, Li XL, Zhang MZ, Guo YL, Zhu CG, Guo LH, Li S, Zhang Y, Li JJ.
    Atherosclerosis; 2014 Dec; 237(2):536-43. PubMed ID: 25463086
    [Abstract] [Full Text] [Related]

  • 4. Association of preprocedural low-density lipoprotein cholesterol levels with myocardial injury after elective percutaneous coronary intervention.
    Li XL, Li JJ, Guo YL, Zhu CG, Xu RX, Li S, Qing P, Wu NQ, Jiang LX, Xu B, Gao RL.
    J Clin Lipidol; 2014 Dec; 8(4):423-32. PubMed ID: 25110224
    [Abstract] [Full Text] [Related]

  • 5. Relationship Between Preoperative Low-Density Lipoprotein Cholesterol and Periprocedural Myocardial Injury in Patients Following Elective Percutaneous Coronary Intervention in Southern China.
    Zhong Z, Liu J, Zhang Q, Zhong W, Li B, Li C, Liu Z, Yang M, Zhao P.
    Med Sci Monit; 2018 Jun 18; 24():4154-4161. PubMed ID: 29910459
    [Abstract] [Full Text] [Related]

  • 6. Preprocedural N-terminal pro-B-type natriuretic peptide as a useful marker for predicting periprocedural myocardial injury following percutaneous coronary intervention in diabetic patients without cardiac dysfunction.
    Zeng RX, Li XL, Zhang MZ, Wang XW, Guo YL, Zhu CG, Ren Y, Li S, Zhang Y, Liu G, Xu RX, Dong Q, Li JJ.
    Scand J Clin Lab Invest; 2015 Nov 18; 75(7):568-77. PubMed ID: 26203960
    [Abstract] [Full Text] [Related]

  • 7. Remnant cholesterol predicts periprocedural myocardial injury following percutaneous coronary intervention in poorly-controlled type 2 diabetes.
    Zeng RX, Li S, Zhang MZ, Li XL, Zhu CG, Guo YL, Zhang Y, Li JJ.
    J Cardiol; 2017 Aug 18; 70(2):113-120. PubMed ID: 28209463
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Age, Sex, and Cardiovascular Risk Attributable to Lipoprotein Cholesterol Among Chinese Individuals with Coronary Artery Disease: A Case-Control Study.
    Wu TT, Zheng YY, Yang YN, Li XM, Ma YT, Xie X.
    Metab Syndr Relat Disord; 2019 May 18; 17(4):223-231. PubMed ID: 30720383
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Association of major adverse cardiovascular events and cardiac troponin-I levels following percutaneous coronary intervention: a three-year follow-up study at a single center.
    Huang ZS, Zheng ZD, Zhang JW, Tang LL, Zhou LL, Li SH, Xie XJ, Dong RM, Zhu JM, Liu JL.
    Eur Rev Med Pharmacol Sci; 2020 Apr 18; 24(7):3981-3992. PubMed ID: 32329875
    [Abstract] [Full Text] [Related]

  • 13. The apoB/apoA-I ratio is better than the cholesterol ratios to estimate the balance between plasma proatherogenic and antiatherogenic lipoproteins and to predict coronary risk.
    Walldius G, Jungner I, Aastveit AH, Holme I, Furberg CD, Sniderman AD.
    Clin Chem Lab Med; 2004 Apr 18; 42(12):1355-63. PubMed ID: 15576296
    [Abstract] [Full Text] [Related]

  • 14. High high-density lipoprotein-cholesterol reduces risk and extent of percutaneous coronary intervention-related myocardial infarction and improves long-term outcome in patients undergoing elective percutaneous coronary intervention.
    Sattler KJ, Herrmann J, Yün S, Lehmann N, Wang Z, Heusch G, Sack S, Erbel R, Levkau B.
    Eur Heart J; 2009 Aug 18; 30(15):1894-902. PubMed ID: 19474052
    [Abstract] [Full Text] [Related]

  • 15. Size, density and cholesterol load of HDL predict microangiopathy, coronary artery disease and β-cell function in men with T2DM.
    Hermans MP, Amoussou-Guenou KD, Bouenizabila E, Sadikot SS, Ahn SA, Rousseau MF.
    Diabetes Metab Syndr; 2017 Aug 18; 11(2):125-131. PubMed ID: 27665027
    [Abstract] [Full Text] [Related]

  • 16. Impact of high-density lipoprotein 3 cholesterol subfraction on periprocedural myocardial injury in patients who underwent elective percutaneous coronary intervention.
    Harada K, Kikuchi R, Suzuki S, Tanaka A, Aoki T, Iwakawa N, Kojima H, Hirayama K, Mitsuda T, Sumi T, Negishi Y, Ishii H, Murohara T.
    Lipids Health Dis; 2018 Feb 02; 17(1):21. PubMed ID: 29391013
    [Abstract] [Full Text] [Related]

  • 17. High-density lipoprotein cholesterol, high-density lipoprotein particle size, and apolipoprotein A-I: significance for cardiovascular risk: the IDEAL and EPIC-Norfolk studies.
    van der Steeg WA, Holme I, Boekholdt SM, Larsen ML, Lindahl C, Stroes ES, Tikkanen MJ, Wareham NJ, Faergeman O, Olsson AG, Pedersen TR, Khaw KT, Kastelein JJ.
    J Am Coll Cardiol; 2008 Feb 12; 51(6):634-42. PubMed ID: 18261682
    [Abstract] [Full Text] [Related]

  • 18. Free fatty acids as a marker for predicting periprocedural myocardial injury after coronary intervention.
    Wang Y, Zhang HW, Guo YL, Zhu CG, Wu NQ, Li JJ.
    Postgrad Med J; 2019 Jan 12; 95(1119):18-22. PubMed ID: 30700582
    [Abstract] [Full Text] [Related]

  • 19. Effect of one-cycle remote ischemic preconditioning to reduce myocardial injury during percutaneous coronary intervention.
    Zografos TA, Katritsis GD, Tsiafoutis I, Bourboulis N, Katsivas A, Katritsis DG.
    Am J Cardiol; 2014 Jun 15; 113(12):2013-7. PubMed ID: 24793669
    [Abstract] [Full Text] [Related]

  • 20. Relation of high-density lipoprotein cholesterol:apolipoprotein a-I ratio to progression of coronary atherosclerosis in statin-treated patients.
    Mani P, Uno K, St John J, Tuzcu EM, Nissen SE, Nicholls SJ.
    Am J Cardiol; 2014 Sep 01; 114(5):681-5. PubMed ID: 25030535
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.